bioRxivMicrobiologyPreprint
A murine commensal protozoan relieves Clostridium difficile infection through regulating the arginine metabolism and the host intestinal immune response
H. Yang, X. Wu, W. Zang, Y. Zhou, X. Li, L. Wang, W. Cui, Y. Kou, Y. Wang, B. Gu
Abstract
Antibiotic-induced dysbiosis is a key predisposing factor for Clostridium difficile infection (CDI), fecal microbiota transplantation (FMT) is recommended for treating CDI. However, the mechanisms remain unclear. Here, we uncover that one integral member of the murine gut microbiota, a commensal protozoan from mice, Tritrichomonas musculis (T. mu), that reduced intestinal damage by inhibiting the recruitment of neutrophil and secretion of IL-1{beta}, and increased Th1 cell differentiation and secretion of IFN-{gamma}, which increased the goblet cell and secretion of mucin to protect the intestinal mucosa. The T. mu upregulated the key enzymes of arginine metabolism iNOS, ASS, OTC and down-regulated ARG1 in CDI mice, resulting in an increase in arginine, citrulline and a decrease in ornithine, which worked together to regulate the host intestinal immune response and alleviate CDI. This work reveals the interaction mechanism between intestinal commensal eukaryotes and pathogenic bacteria, and also provide new ideas for treating CDI.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The mechanisms of in vivo commensal control of Clostridioides difficile virulence
B. P. Girinathan, N. DiBenedetto, … L. Bry·bioRxiv·Jan 4, 2020
- Simplified fecal community transplant restores Clostridioides difficile colonization resistance to antibiotic perturbed murine communities
N. A. Lesniak, S. Tomkovich, … P. D. Schloss·bioRxiv·May 11, 2022
- Intestinal inflammation reversibly alters the microbiota to drive susceptibility to Clostridioides difficile colonization in a mouse model of colitis
M. R. Barron, K. L. Sovacool, … V. B. Young·bioRxiv·Apr 7, 2022
- Alterations in intestinal Proteobacteria and antimicrobial resistance gene burden in individuals administered microbial ecosystem therapeutic (MET-2) for recurrent Clostridioides difficile infection
A. M. Rooney, K. Cochrane, … B. Coburn·bioRxiv·Nov 4, 2022
- Host origin of microbiota drives functional recovery and Clostridioides difficile clearance in mice
Sophie Millard, Kimberly C. Vendrov, … Anna Maria Seekatz·mBioPeer-reviewed·Jun 2, 2025
- Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota
J. R. Fletcher, C. M. Pike, … C. M. Theriot·bioRxiv·Aug 6, 2020